SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-099451
Filing Date
2024-09-12
Accepted
2024-09-12 21:37:15
Documents
2
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2423876-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2423876-2_3seq1.xml 3 1612
2 EXHIBIT 24 tm2423876d2_ex24.htm EX-24 7943
  Complete submission text file 0001104659-24-099451.txt   11084
Mailing Address C/O ENAVATE SCIENCES 2884 SAND HILL RD., STE 100 MENLO PARK CA 94025
Business Address
Boylan James P (Reporting) CIK: 0001953094 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42270 | Film No.: 241296307

Mailing Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451
Business Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Issuer) CIK: 0001953926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)